Pulmonary hypertension (PH) refers to elevated pressure in the vessels of the lungs. If affected, the arteries and veins in the lungs become narrow and stiff. As the result, the right side of the heart has to work harder to pump blood through the lungs. If left untreated, PH can lead to right heart failure.
The Pulmonary Hypertension Program at Inova Fairfax Hospital provides the highly specialized multi-disciplinary care required by patients dealing with various types of PH. Inova's lung experts are nationally-recognized for their expertise in diagnosing, treating and managing PH, utilizing the most effective treatments available. Our program has long been recognized for its research of different forms of pulmonary hypertension.
Patients receiving care from the Inova Pulmonary Hypertension Program have seamless access to numerous other medical and support programs. You can talk with the staff about any of the following options.
- Pulmonary rehab: call 703-776-3671
- Interventional radiology: call 703-776-3570
- Palliative care: call 703-776-3203, or email Susan Perry, susan.perry@inova.org, for referral
Dedication to holistic care of PH patients continues at our facility. Family members are encouraged to attend all appointments.
Specialty services
Specialty consultant services are available, including:
- Rheumatology
- Congenital heart disease clinic (medical and surgical)
- Interventional cardiology
- Lung transplant
- Nutrition
- Pulmonary Rehabilitation
In-hospital supportive services
- Thoracic imaging
- Nuclear medicine
- Cardiac anesthesia
- IAC-certified ECHO lab
- Pulmonary diagnostics
- Interventional radiology
Pulmonary Hypertension (PH) Support Groups
PH Support Group for patients with PH and their family members. Meets several times a year. Contact Betsie Miklos, bmiklos@miklos.com or 703-244-7517.
Websites for more information
Our Team
As advocates in the pulmonary hypertension medical community, our team, led by Director Oksana Shlobin, MD, participates in fundraising, outreach and education and serves in leadership positions with organizations worldwide working to improve the lives of patients living with PH, including:
American College of Chest Physicians (ACCP)
- Vice-Chair, Cardiovascular and Pulmonary Vascular Disease Network, Dr. Shlobin
- Oversight Committee and Venous Thromboembolism Treatment Guidelines Committee, Dr. King
Pulmonary Hypertension Association (PHA)
- Oversight Committee, Dr. Shlobin
- Pulmonary Hypertension Professionals Network (PHPN) symposium contributor, Dr. Shlobin
- Liaison Committee, Dr. Khangoora
- Accreditation Committee, Dr. Chris Thomas, Nikki Sisserson, PA
Pulmonary Fibrosis Foundation (PFF)
- Group 3 PH Committee, Dr. Shlobin
- Group 3 PH and Rural Outreach Committees, Dr. King
Pulmonary Vascular Research Institute (PVRI)
- Chair, International Drug Development Institute (IDDI), Group 3 PH Committee, Dr. Nathan
- International Drug Development Institute (IDDI), Group 3 PH Committee, Dr. Shlobin
- Lung Transplantation Committee, Dr. Khangoora
World Symposium on Pulmonary Hypertension (WSPH) Association
- 2024 Chair of the Taskforce of Pulmonary Hypertension in Chronic Lung Diseases, Dr. Shlobin
- 2018 Chair of the Taskforce of Pulmonary Hypertension in Chronic Lung Diseases, Dr. Nathan
